I agree that this site is using cookies. You can find further informations here.
X
Tebbutt, Niall C
91  results:
OpenAccess-fulltext X
Search for persons X
?
1

Unified framework for patient-derived, tumor-organoid-based..:

Tan, Tao ; Mouradov, Dmitri ; Lee, Margaret...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10783557/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in..:

Tan, Lavinia ; Tran, Ben ; Tie, Jeanne...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011885/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

SCORE: a randomised controlled trial evaluating shared care..:

Jefford, Michael ; Emery, Jon D ; James Martin, Andrew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10716007/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewi..:

Jenkins, Laura J ; Luk, Ian Y ; Fairlie, W. Douglas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808369/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Evaluating the Time Toxicity of Cancer Treatment in the CCT..:

Gupta, Arjun ; O'Callaghan, Christopher J ; Zhu, Liting...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337749/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

INTEGRATE II: randomised phase III controlled trials of reg..:

Lam, Lyn Ley ; Pavlakis, Nick ; Shitara, Kohei...
BMC Cancer, Vol.23 No.1, p. 12885.  , 2023
Link: https://hdl.handle.net/1..
 
?
7

Author Correction: DUSP5 is methylated in CIMP-high colorec..:

Tögel, Lars ; Nightingale, Rebecca ; Wu, Rui...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918726/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

INTEGRATE II: randomised phase III controlled trials of reg..:

Lam, Lyn Ley ; Pavlakis, Nick ; Shitara, Kohei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945618/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Author Correction : DUSP5 is methylated in CIMP-high colore..:

Tögel, Lars ; Nightingale, Rebecca ; Wu, Rui...
Scientific reports.  , 2023
Link: https://ddd.uab.cat/reco..
 
?
10

INTEGRATE II: randomised phase III controlled trials of reg..:

Lam, Lyn Ley ; Pavlakis, Nick ; Shitara, Kohei...
BMC Cancer, 23(1):180.  , 2023
Link: https://hdl.handle.net/1..
 
?
11

Randomized, Double-Blind, Placebo-Controlled Phase III Stud..:

Shah, Manish A ; Shitara, Kohei ; Lordick, Florian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433958/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms a..:

Chionh, Fiona ; Gebski, Val ; Al-Obaidi, Sheren J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786898/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Randomized, Double-Blind, Placebo-Controlled Phase III Stud..:

Shah, Manish A ; Shitara, Kohei ; Lordick, Florian...
Clinical Cancer Research, Vol.28 No.17, pp.3686-3694.  , 2022
Link: https://hdl.handle.net/1..
 
?
14

Sex-related disparities in outcomes of cholangiocarcinoma p..:

Ledenko, Matthew ; Antwi, Samuel O ; Arima, Shiho...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404243/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Prognostic significance of postsurgery circulating tumor DN..:

Tie, Jeanne ; Cohen, Joshua D ; Lo, Serigne N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818130/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15